Company profile
UK company 06403643, incorporated on 18 October 2007.
Evgen Pharma | Sulforaphane-Based Clinical Drug Development
Evgen Pharma is a clinical drug development company developing sulforaphane-based medicines focussed on the treatment of cancer and inflammation.
Company number 06403643
Updated 07 Jul 2026 09:49
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
Last confirmation statement made up date
Last accounts made up date
Company registered at Companies House
1 Jul 2012 to 31 May 2013
Sulforaphane, a small molecule of botanical origin, has previously shown significant clinical promise for treating some forms of cancer. However, it is highly unstable rendering it - until now - a nonviable pharmaceutical. In a significant technical breakthrough, Evgen is now able to stabilise a synthetic sulforaphane - extending shelf life from hours to ...
